SCHEMBL6658870

SCHEMBL6658870

CC(C)(O)COc1ncc(C(F)(F)F)cc1-c1cccc(S(C)(=O)=O)c1

nearest known ligand 0.78

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 19/20 0.78
PTGS1 P23219 7/20 0.52
PTGDR2 Q9Y5Y4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6659501 0.91 PTGS2 (0.65) PTGS2PTGS1PTGDR2
SCHEMBL6658251 0.90 PTGS2 (0.64) PTGS2PTGS1PTGDR2
SCHEMBL6656801 0.90 PTGS2 (0.63) PTGS2PTGS1PTGDR2
SCHEMBL6664476 0.90 PTGS2 (0.63) PTGS2PTGS1PTGDR2
SCHEMBL6662707 0.89 PTGS2 (0.64) PTGS2PTGS1PTGDR2
SCHEMBL6660522 0.89 PTGS2 (0.62) PTGS2PTGS1PTGDR2
SCHEMBL6658868 0.88 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL6662781 0.85 PTGS2 (0.58) PTGS2PTGS1PTGDR2
SCHEMBL6675629 0.85 PTGS2 (0.61) PTGS2PTGS1PTGDR2
SCHEMBL6660825 0.85 PTGS2 (0.60) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1012142-B1 2,3,5-TRISUBSTITUTED PYRIDINES AS INHIBITORS OF CYCLOOXYGENASE-2 MERCK FROSST CANADA INC (CA) 2004-08-11 EP claimed
US-6046217-A TREATING AN INFLAMMATORY DISEASE SUSCEPTIBLE TO TREATMENT WITH A NON-STEROIDAL ANTI-INFLAMMATORY AGENT COMPRISING ADMINISTERING TO A PATIENT IN NEED OF SUCH TREATMENT A NONTOXIC 3-PHENYL SUBSTITUTED PYRIDINES MERCK FROSST CANADA & CO. (CA) 2000-04-04 US claimed
EP-1012142-B1 2,3,5-TRISUBSTITUTED PYRIDINES AS INHIBITORS OF CYCLOOXYGENASE-2 MERCK FROSST CANADA INC (CA) 2004-08-11 EP disclosed
US-6046217-A TREATING AN INFLAMMATORY DISEASE SUSCEPTIBLE TO TREATMENT WITH A NON-STEROIDAL ANTI-INFLAMMATORY AGENT COMPRISING ADMINISTERING TO A PATIENT IN NEED OF SUCH TREATMENT A NONTOXIC 3-PHENYL SUBSTITUTED PYRIDINES MERCK FROSST CANADA & CO. (CA) 2000-04-04 US disclosed